Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats.

In health insulin is secreted in discrete insulin secretory bursts from pancreatic beta-cells, collectively referred to as beta-cell mass. We sought to establish the relationship between beta-cell mass, insulin secretory-burst mass, and hepatic insulin clearance over a range of age-related insulin sensitivity in adult rats. To address this, we used a novel rat model with chronically implanted portal vein catheters in which we recently established the parameters to permit deconvolution of portal vein insulin concentration profiles to measure insulin secretion and resolve its pulsatile components. In the present study, we examined total and pulsatile insulin secretion, insulin sensitivity, hepatic insulin clearance, and beta-cell mass in 35 rats aged 2-12 mo. With aging, insulin sensitivity declined, but euglycemia was sustained by an adaptive increase in fasting and glucose-stimulated insulin secretion through the mechanism of a selective augmentation of insulin pulse mass. The latter was attributable to a closely related increase in beta-cell mass (r=0.8, P<0.001). Hepatic insulin clearance increased with increasing portal vein insulin pulse amplitude, damping the delivery of insulin in the systemic circulation. In consequence, the curvilinear relationship previously reported between insulin secretion and insulin sensitivity was extended to both insulin pulse mass and beta-cell mass vs. insulin sensitivity. These data support a central role of adaptive changes in beta-cell mass to permit appropriate insulin secretion in the setting of decreasing insulin sensitivity in the aging animal. They emphasize the cooperative role of pancreatic beta-cells and the liver in regulating the secretion and delivery of insulin to the systemic circulation.

[1]  P. Butler,et al.  Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein. , 2008, American journal of physiology. Endocrinology and metabolism.

[2]  A. DeAngelis CEACAM1: A Link Between Insulin and Lipid Metabolism , 2008 .

[3]  R. Rizza,et al.  β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans , 2008, Diabetes.

[4]  W. Uhl,et al.  Partial Pancreatectomy in Adult Humans Does Not Provoke β-Cell Regeneration , 2008, Diabetes.

[5]  W. Uhl,et al.  Partial pancreatectomy in adult humans does not provoke beta-cell regeneration. , 2008, Diabetes.

[6]  Xueying Gu,et al.  Menin Controls Growth of Pancreatic ß-Cells in Pregnant Mice and Promotes Gestational Diabetes Mellitus , 2007, Science.

[7]  R. Rizza,et al.  High Expression Rates of Human Islet Amyloid Polypeptide Induce Endoplasmic Reticulum Stress–Mediated β-Cell Apoptosis, a Characteristic of Humans With Type 2 but Not Type 1 Diabetes , 2007, Diabetes.

[8]  J. Kench,et al.  Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes , 2007, Diabetologia.

[9]  Seung K. Kim,et al.  Intrinsic Regulators of Pancreatic β-Cell Proliferation , 2006 .

[10]  P. Butler,et al.  Mechanisms of Impaired Fasting Glucose and Glucose Intolerance Induced by a ∼50% Pancreatectomy , 2006, Diabetes.

[11]  P. Butler,et al.  β-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes , 2006, Diabetes.

[12]  H. Wootz,et al.  ER stress and neurodegenerative diseases , 2006, Cell Death and Differentiation.

[13]  A. Chang,et al.  Limitation of the homeostasis model assessment to predict insulin resistance and beta-cell dysfunction in older people. , 2006, The Journal of clinical endocrinology and metabolism.

[14]  Seung K. Kim,et al.  Intrinsic regulators of pancreatic beta-cell proliferation. , 2006, Annual review of cell and developmental biology.

[15]  P. Butler,et al.  Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. , 2006, Diabetes.

[16]  J. Kushner,et al.  Very Slow Turnover of β-Cells in Aged Adult Mice , 2005 .

[17]  Johannes D Veldhuis,et al.  Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. , 2005, Diabetes.

[18]  O. McGuinness,et al.  Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake. , 2005, American journal of physiology. Endocrinology and metabolism.

[19]  J. Kushner,et al.  Very slow turnover of beta-cells in aged adult mice. , 2005, Diabetes.

[20]  Gil Atzmon,et al.  Decrease in glucose-stimulated insulin secretion with aging is independent of insulin action. , 2004, Diabetes.

[21]  R. DeFronzo,et al.  Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus , 1982, Diabetologia.

[22]  W. Soeller,et al.  Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. , 2003, Diabetes.

[23]  Claudio Cobelli,et al.  Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. , 2003, Diabetes.

[24]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[25]  S. Najjar Regulation of insulin action by CEACAM1 , 2002, Trends in Endocrinology & Metabolism.

[26]  Y. Kido,et al.  CEACAM1 regulates insulin clearance in liver , 2002, Nature Genetics.

[27]  M. Stumvoll,et al.  Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans. , 2002, Diabetes.

[28]  Jean-Pierre Paccaud,et al.  Two Steps of Insulin Receptor Internalization Depend on Different Domains of the/3-Subunit , 2002 .

[29]  M. Straume,et al.  Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. , 2001, Diabetes.

[30]  J D Veldhuis,et al.  Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. , 2000, The Journal of clinical endocrinology and metabolism.

[31]  R. Bergman,et al.  Longitudinal Compensation for Fat-induced Insulin Resistance Includes Reduced Insulin Clearance and Enhanced ␤-cell Response Research Design and Methods , 2022 .

[32]  N. Porksen,et al.  Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. , 2000, American journal of physiology. Endocrinology and metabolism.

[33]  E. Montanya,et al.  Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy. , 2000, Diabetes.

[34]  N. Barzilai,et al.  Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation. , 2000, American journal of physiology. Endocrinology and metabolism.

[35]  E. Montanya,et al.  Linear Correlation Between -Cell Mass and Body Weight Throughout the Lifespan in Lewis Rats Role of -Cell Hyperplasia and Hypertrophy , 2000 .

[36]  J D Veldhuis,et al.  Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals. , 1999, The Journal of clinical endocrinology and metabolism.

[37]  A Mari,et al.  Free fatty acids impair hepatic insulin extraction in vivo. , 1999, Diabetes.

[38]  N. Barzilai,et al.  Surgical removal of visceral fat reverses hepatic insulin resistance. , 1999, Diabetes.

[39]  W. Duckworth,et al.  Insulin degradation: progress and potential. , 1998, Endocrine reviews.

[40]  G Pacini,et al.  Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. , 1998, The Journal of clinical endocrinology and metabolism.

[41]  Wei Chen,et al.  Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. , 1998, The Journal of clinical investigation.

[42]  N. Porksen,et al.  Effects of Glucose Ingestion Versus Infusion on Pulsatile Insulin Secretion: The Incretin Effect Is Achieved by Amplification of Insulin Secretory Burst Mass , 1996, Diabetes.

[43]  N. Porksen,et al.  Effects of somatostatin on pulsatile insulin secretion: elective inhibition of insulin burst mass. , 1996, The American journal of physiology.

[44]  N. Porksen,et al.  Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting. , 1995, The American journal of physiology.

[45]  J. Sturis,et al.  Alterations in the Patterns of Insulin Secretion Before and After Diagnosis of IDDM , 1995, Diabetes Care.

[46]  S. Bonner-Weir,et al.  Dynamics of β-cell Mass in the Growing Rat Pancreas: Estimation With a Simple Mathematical Model , 1995, Diabetes.

[47]  J. Leahy,et al.  Diazoxide Causes Recovery of β-Cell Glucose Responsiveness in 90% Pancreatectomized Diabetic Rats , 1994, Diabetes.

[48]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[49]  L Orci,et al.  Two steps of insulin receptor internalization depend on different domains of the beta-subunit [published erratum appears in J Cell Biol 1993 Nov;123(4):1047] , 1993, The Journal of cell biology.

[50]  A. Goldberg,et al.  Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. , 1992, The Journal of clinical endocrinology and metabolism.

[51]  A. Valerio,et al.  Reduced Beta‐Cell Secretion and Insulin Hepatic Extraction in Healthy Elderly Subjects , 1990, Journal of the American Geriatrics Society.

[52]  A. Ullrich,et al.  Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor beta-subunit. , 1990, The Journal of biological chemistry.

[53]  M. Cerqueira,et al.  Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. , 1990, The American journal of physiology.

[54]  R. Rizza,et al.  Effects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans , 1990, Diabetes.

[55]  P. Björntorp,et al.  Free–Fatty Acid Inhibition of Insulin Binding, Degradation, and Action in Isolated Rat Hepatocytes , 1990, Diabetes.

[56]  K. Polonsky,et al.  Effects of Aging on Insulin Secretion , 1989, Diabetes.

[57]  D. Owens,et al.  INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[58]  J. Olefsky,et al.  The Metabolic Clearance of Insulin and the Feedback Inhibition of Insulin Secretion Are Altered with Aging , 1985, Diabetes.

[59]  D. James,et al.  Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. , 1985, The American journal of physiology.

[60]  M. Löhr,et al.  Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. , 1985, Survey and synthesis of pathology research.

[61]  E. Bonora,et al.  Decreased hepatic insulin extraction in subjects with mild glucose intolerance. , 1983, Metabolism: clinical and experimental.

[62]  H. Kehlet,et al.  Decreased insulin removal contributes to hyperinsulinemia in obesity. , 1981, The Journal of clinical endocrinology and metabolism.

[63]  Claudio Cobelli,et al.  Physiologic Evaluation of Factors Controlling , 1981 .

[64]  K. Kosaka,et al.  Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes. , 1980, The Journal of clinical endocrinology and metabolism.

[65]  D. Kipnis,et al.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. , 1967, The Journal of clinical investigation.

[66]  M. T. Brennan,et al.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. , 1967, The Journal of clinical investigation.